Rosetta Genomics Raises $1.75M, Negotiating for Additional $1.25M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics announced today it has raised $1.75 million in a private placement, and is negotiating for another $1.25 million.

The $1.75 million was raised through the sale of senior secured debentures to an unnamed accredited investor. The debentures have a maturity date of Jan. 26, 2013 and accrue interest at 10 percent annually, payable semi-annually.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.